Hovione Macau

Manufacturing Plant

Established in 1986, the site was first approved by the FDA in 1987 and is regularly inspected.

Manufacturing Plant in Macau, China | Hovione

Hovione Macau was established in 1986 and has since been upgraded to boost production capacity as well as to install waste water treatment facilities. The plant was first approved by the FDA in 1987 and is regularly inspected. The plant holds a GMP Certificate issued by Infarmed, the Portuguese Health Authority.

With a total reactor capacity of approximately 100m3, Hovione Macau produces both generic and custom synthesis products. The plant benefits from its proximity to the People’s Republic of China for the supply of raw materials.

Area of Focused Expertise

The site has leading capabilities and physical assets in the following areas:

  • Cryogenic (Volume 6000L, Temperature Range -65 to 140ºC)
  • Hydrogenation (Volume 600L to 6000L, Pressure Rating 10 to 20bar)
  • Tetracycline and Macrolide chemistry

For details about production equipment – click here

Operations

  • The Macau plant operates 24 hours a day 7 days a week.
  • Quality Control labs supports production 24 hours a day 7 days a week.
  • Plant maintenance shutdown period takes place for 3 to 4 weeks in August.

Certifications

The site is certified in accordance with the ISO9001; ISO14001 and OHSAS18001.

 

 
 

For inquiries about Hovione Macau, kindly fill the form below.

News

Lisbon, Portugal – Hovione, the specialist integrated pharma CDMO and leader in spray drying and particle engineering, today announced its commitment to setting Science-Based Targets (SBTs) in line with the Paris Agreement. This ambitious step underscores the company’s dedication to addressing climate change and driving sustainability across its operations. By committing to SBTs, Hovione joins a growing number of businesses taking concrete actions to reduce greenhouse gas emissions. This initiative aligns with the company’s broader sustainability strategy and reinforces its commitment to scientific excellence. “At Hovione, we believe in science and in best practices. And this clearly applies to our sustainability agenda.”, said Jean-Luc Herbeaux, CEO of Hovione. We made the decision to drive our GHG emissions down using a science-based target setting process, which will help us drive sustainability across our operations by laying out a clearly defined path to reduce emissions in line with the Paris Agreement goals. We believe that by setting ambitious targets and implementing concrete actions, we can make a positive impact on the planet while driving innovation and growth.” Hovione will work closely with the Science Based Targets initiative (SBTi) to develop and validate its emission reduction targets. The company will provide regular updates on its progress towards achieving these goals. As part of its commitment to sustainability and transparency to stakeholders, the company will enhance its Ecovadis rating. Ecovadis, a leading sustainability assessment platform in the pharmaceutical industry, provides a comprehensive evaluation of a company’s environmental, social, and ethical performance, well aligned with Hovione’s sustainability ambitions.  Hovione remains dedicated to operating responsibly and contributing positively to society and the environment. The company will continue to implement sustainable practices across its operations and innovate to further improve its sustainability rating.   Learn more about Science Based-Targets  

News

Hovione Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions

Sep 09, 2024
Manufacturing Plant
Address

Hovione PharmaScience Ltd
Estrada Coronel Nicolau de Mesquita
Taipa
Macau
Tel: +853 2882 7544
Fax: +853 2882 7714
e-mail: infohm@hovione.com
DUNS Nr: 854974342 
Location: 22°09'28.62" N  113°33'40.58" E

FDA logo | Hovione
infarmed logo | Hovione
Hovione MACAU - ISO14001 and ISO45001
HKQAA Certified Company | Hovione

Other Locations

Hovione Hong Kong

Office
Address

Hovione Holding Asia Limited
Aubin House, 11th Floor
171-172 Gloucester Road
Wanchai
Hong Kong SAR
Tel.: +852 2891 1836
Fax: +852 2891 0943 

Hovione India

Office
Address

Hovione Holding Limited
C/o WeWork, 2nd floor,
Oberoi Commerz - II,  1,
Off Western Express Highway,
Oberoi Garden City, Goregaon East, Mumbai, Maharashtra 400063
India
Tel.: +919 004 261 523

Hovione Beijing

Office
Address

Hovione (Shanghai) Pharma Technology Limited Beijing Branch
Room 1003-1, 10/F, Sanyuan NEO Xinjing Building, Building 18, No. 5 Shuguang Xili, Chaoyang District, Beijing, China
Tel.: +86-18500027185
Tel.: +86-19931153253 

contact@hovione.com